Scientific Research Qui Tam Cases

Cases involving scientific research qui tam actions often center on the liability of hospitals, universities, or research institutions that submit false or misleading information to obtain federal research funding. These claims typically arise when institutions fail to comply with the conditions tied to grants or contracts from federal agencies such as the National Institutes of Health (NIH) or other government entities.

Federal funding is intended to advance legitimate medical and scientific research. When an organization misrepresents data, inflates costs, or fails to meet ethical or regulatory requirements, those actions can constitute fraud under the False Claims Act (FCA). In many instances, scientific research whistleblowers—often employees, contractors, or researchers—come forward with inside knowledge of improper practices involving grant proposals, expenditure reporting, or research compliance violations. Their disclosures can lead to significant recoveries for the government and protect the integrity of federally funded research.

Research Grant Fraud and Compliance Violations

A county hospital that receives federal grants to fund a research program may be held liable under the False Claims Act for failing to comply with required conditions of that grant. For example, a qui tam scientific research whistleblower alleged that a county hospital, which had obtained a grant to study potential treatment options for pregnant drug addicts, failed to adhere to federal regulations governing research on human subjects. Because the hospital did not follow the mandated ethical and procedural safeguards, it faced potential FCA liability.

These cases underscore how critical it is for research entities to maintain full compliance with federal standards. Violations can include misuse of funds, falsified data, billing for unapproved research costs, or failure to obtain proper institutional review board (IRB) approval. The False Claims Act provides a legal avenue for whistleblowers to report such misconduct and, in turn, to receive a share of the government’s recovery when fraud is proven.

Notice

This website is designed to provide general information only. This information is not and should not be construed to be legal advice. The transmission of the information found on this website also does not result in the formation of a lawyer-client relationship.

You should be aware that qui tam claims are subject to a Statute of Limitations. The area of limitations periods is complex. There are also first to file rules, public disclosure bars, original source issues, and varying limitations in pursuing retaliation claims. If you wish to pursue your claims, you should promptly seek the opinion of an attorney regarding the merits of your qui tam claim and the applicable statute of limitations.

Free Consultation

Questions about the False Claims Act, Tax Fraud or the Financial Fraud Programs and whether or not you have a case? Submit our confidential form and the Law Offices of David Berg will evaluate your potential case immediately.

Law Offices of David Berg

The Law Offices of David Berg tries big cases. Over the years, David Berg, as both plaintiff and defense counsel, has represented Westinghouse, CBS, Samsung, Robert Bass’ Acadia Partners, L.P., Deutsche Bank, Credit Suisse, and other major companies. These cases range from a dispute over nuclear steam generators to a billion dollar patent infringement case to complex securities class actions.

Contact Us

708 Main, 10th floor
Houston, Texas, 77002

(713) 529-5622

general@bafirm.com

Attorney Advertising. Results obtained depend on the facts of each case. Prior results do not guarantee a similar outcome. Copyright 2015-2026, Law Offices of David Berg, All Rights Reserved.